We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA issued a warning letter to Dallas-based manufacturer EEMSO for "significant violations" of the quality system (QS), including medical device reporting (MDR) and device listing regulations.